Trademark: 79374701
Word
LAVEROCK THERAPEUTICS
Status
Pending
Status Code
645
Status Date
Thursday, May 23, 2024
Serial Number
79374701
Mark Type
4
Filing Date
Thursday, January 19, 2023

Trademark Owner History

Classifications
9 downloadable computer software in the field of biotechnology for identifying genetic abnormalities and immune system disorders; downloadable bioinformatics software for identifying genetic abnormalities and immune system disorders; downloadable sequencing software for identifying gnetic abnormalities and immune system disorders; downloadable software featuring algorithms in the field of biotechnology to assist in the manufacturing of gene silencing pharmaceuticals; downloadable big data management software; downloadable machine learning software; testing apparatus, namely, downloadable software used for testing genetic markers and the human immune system; downloadable computer software platforms for medical research purposes; downloadable mobile applications for use in gene silencing therapies; downloadable software for scientific analysis of genetic sequences; downloadable software for performing medical diagnostics; downloadable software for remote diagnostics of genetic abnormalities and immune system disorders; downloadable reporting software; downloadable product engineering software; downloadable software for remote diagnostics; downloadable data storage programs; laboratory apparatus and instruments, namely, laboratory devices for detecting genetic sequences; diagnostic apparatus for the detection of pathogens for scientific or research purposes; cell culture apparatus for laboratory use, namely, cell culture dishes and tissue culture flasks; laboratory devices for detecting genetic sequences; bioreactors for laboratory use; bioreactors for cell culturing for scientific research; gene amplifiers for laboratory use; electrical equipment for the genetic modification of cells for research purposes; laboratory instruments for the detection of pathogens and toxins in a biological sample for research use; devices for analysing gene sequences and pathogens used as laboratory apparatus; laboratory chemical reactors; nucleic acid sequencers for scientific purposes; research laboratory analysers for measuring, testing and analysing blood and other bodily fluids; sensors, detectors and monitoring instruments, being downloadable software used for the treatment of diabetes; sensors for determining chemical levels in aqueous solutions for research purposes; biochip sensors; measuring sensors; photometric apparatus; temperature regulation devices in the nature of thermostats; temperature controllers and indicators for warming and cooling medical and surgical liquids, equipment and instruments; cell culture apparatus for laboratory use, namely, cell culture dishes; parts and fittings for all the aforesaid goods
39 Storage of human cells for medical use; storage of goods in refrigerated conditions; cryogenic storage of biological tissues; refrigerated storage services; storage of surgical instruments and equipment; packaging and storage of goods; storage of liquids; bulk storage of biomedical compounds; rental of refrigerated storage; transportation services, namely, transportation of biomedical compounds by road; transportation of pharmaceuticals by road; temperature controlled storage of chemicals; consultancy, information and advisory services relating to all of the aforesaid services
5 Pharmaceutical, medical and veterinary preparations for use in gene silencing therapies; drugs for medical purposes, namely, preparations for identifying genetic markers, blood grouping purposes and detecting mutation in prion genes for medical purposes; biological preparations for use in medical genetic testing and for use in detecting genetic predispositions for medical purposes; therapeutic preparations, namely, preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; diagnostic biomarker reagents for medical purposes; genetic markers for use in genetic testing, for medical use; cells for medical use; recombinant protein being biochemical preparations for medical or veterinary purposes for use in immuno-pharmaceuticals and gene silencing pharmaceuticals; medical diagnostic reagents; cultures of microorganisms for medical or veterinary use; enzymes for medical purposes; food supplements; yeast for medical purposes; diagnostic preparations; RNA synthesis inhibitors for treating genetic abnormalities; pharmaceutical preparations for the prevention or treatment of tumors; pharmaceutical preparations for the prevention or treatment of diabetes; pharmaceutical preparations for activating cellular function; stem cells for medical purposes; cell growth media for growing cells for medical use; cellular function activating agents for medical purposes; reconstituted cells for medical treatments; preparations for detecting genetic predispositions for medical purposes; preparations for detecting mutation in prion genes for medical purposes; nucleic acid sequences for medical and veterinary purposes; nucleic recombinant acids for medical or veterinary use; nucleic acid amplification reagents for medical use; RNA silencers being chemical preparations for medical purposes; biological preparations for medical purposes for the treatment of genetic abnormalities and immune system disorders; diagnostic biomarker reagents for medical use; biological tissue cultures for medical purposes; media for bacteriological cultures; cultures of microorganisms for medical and veterinary use; growth promoters or stimulants for medical use in generating cell reproduction; in vitro diagnostic preparations for medical use; biological indicators for genetic abnormalities for medical diagnosis; in vivo diagnostic scanning agents for medical use; diagnostic agents for pharmaceutical or medical use; diagnostic biomarker reagents for medical purposes; diagnostic reagents for medical or veterinary use; reagents for use in medical genetic testing; immunoassay reagents for medical purposes; antibody reagents used for the detection of antigens in cells and tissue for medical purposes; medical diagnostic reagents for microbiological analysis; medical diagnostic reagents for use in genetic programming, for medical purposes; reagents for use in medical genetic testing; diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in gene silencing therapies; diagnostic test kits comprising peptide substrates used in analyzing and detecting certain toxins for medical purposes; medical diagnostic test strips for use in the fields of genetic disorders and diseases; diagnostic chemical preparations for use in antibiotic susceptibility testing for medical use; chemical reagents for in-vitro genetic testing or microbiological analysis for medical purposes; chemical reagents for analysis or blood grouping purposes for medical or veterinary purposes; medicines for human purposes, namely, medicines for the treatment of genetic diseases and disorders; vaccines; tumor antigens; pharmaceutical agents affecting sensory organs; pharmaceutical preparations for the treatment of immune system related diseases and disorders; nutraceutical preparations for therapeutic or medical purposes, namely, for treating immune system related diseases and disorders; chemical diagnostic reagents for medical use; chemical preparations for the diagnosis of diabetes; chemical reagents for use in multiplying nucleic acid amounts for medical purposes; chemical reagents for use in performing nucleic acid polymerase chain reactions for medical purposes; chemical reagents having antimicrobial properties for medical or veterinary purposes; anti-bacterial preparations for treating genetic diseases and immune system disorders; monoclonal antibodies for medical or veterinary use; antimicrobial preparations for inhibiting microbiological decomposition; antiviral antibiotics; bacterial preparations for medical purposes; immunotherapeutic agents for bacterial infections; probiotic bacterial preparations for medical use; enzymes for use in isothermal amplifications for medical use; enzymes for medical purposes for use in the continuous homogenous isothermal amplifications of specific RNA or DNA templates; yeast extracts for medical, veterinary or pharmaceutical purposes; blood serums containing antibodies for medical diagnostic purposes; medicated serums for treatment of skin conditions; skin lotions for pharmaceutical purposes; therapeutic creams, namely, topical analgesic creams; blood components, namely, plasma, red blood cells, white blood cells and platelets; blood substitutes for the treatment of blood diseases; dietary supplements; chemical reagents for cryopreservation for medical purposes; pharmaceutical preparations for cryopreservation for medical purposes; therapeutic preparations in the nature of cell-based gene therapies containing stem cells; stem cells for medical use; chemical stabilisers for pharmaceuticals; chemicals to maintain viability for pharmaceuticals; medical diagnostic test assays for medical purposes for testing cell potency, cell identity, cell purity, cell stability, cell sterility and cell viability; transplants, namely, implants comprising living tissues; surgical implants comprising living tissue; implants comprising living tissue; surgical implants comprising live organs and tissues; surgical implants grown from stem cells; vascular grafts; biological cells and skin tissues for medical implantation; biological tissue cultures for medical purposes; pharmaceutical preparations for use in living tissue transplantation; living tissues with defined cell ratios for surgical implantation; pharmaceutical preparations for treatment in tissue implantation; living tissue-regenerative pharmaceutical preparations; pharmaceutical preparations for the treatment of infectious diseases, viral diseases, parasitic diseases, autoimmunity conditions, vascular diseases, lymphedema, inflammatory diseases, gastrointestinal diseases, neurological conditions, Musculo-skeletal diseases, orthopaedic conditions, dermatological conditions, ophthalmic conditions, respiratory diseases, pain, sensory disorders, genitourinary conditions, hormonal conditions, metabolic conditions, monogenic diseases or age-related disorders
1 Chemical preparations for use in identifying genetic markers; chemical preparations used for blood grouping purposes, manufacturing immuno-pharmaceuticals and manufacturing gene silencing pharmaceuticals; chemical substances for analysis for medical research; chemical substances for use in the manufacture of pharmaceutical products; cells for scientific or research purposes; reagents for research use; bacteria for scientific and research purposes; cultures of microorganisms other than for medical or veterinary use; enzymes for scientific purposes; protein in raw material form for scientific and medical research; diagnostic preparations for scientific or research use; chemicals for use in science; chemicals for use in the manufacturing of pharmaceuticals; chemicals for use in biotechnological manufacturing processes or product development; chemical preparations for scientific diagnostic use; nucleic recombinant acids for laboratory use, scientific use and research purposes; nucleic acid sequencing preparations, other than for medical and veterinary use; nucleic acid amplification reagents other than for medical and veterinary use; chemical reagents for use in genetic research; reagents for medical research; reagents for science or research purposes; diagnostic preparations for scientific or research use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents, except for medical or veterinary use; stem cells for research or scientific purposes; cell growth media for growing cells for scientific use; cell culture media for use in the biotechnological industry; cell culture reagents for scientific and research use; reconstituted cells for the efficiency or tolerance testing of pharmaceutical products; reconstituted cells for the efficiency or tolerance testing of chemical preparations; chemicals for use in molecular separation processes, other than medical use; chemicals for use in performing nucleic acid polymerase chain reactions other than for medical and veterinary purposes; reagents for laboratory, analytical or blood grouping purposes other than for medical or veterinary purposes; chemical reagents for use in biotechnology, other than for medical or veterinary use; biological preparations for use in cell cultures other than for medical or veterinary use; biochemicals for in vitro and in vivo scientific use; biochemicals, namely, precursors for in vitro genetic engineering use; biological preparations for use in science; biological activators for the manufacture of pharmaceuticals; chemical reagents for molecular biology, other than for medical or veterinary use; chemicals having antimicrobial properties for scientific, laboratory and research purposes other than medical or veterinary; cell culture media for microbiology, for scientific and research purposes; cultures of microorganisms, viruses and tissue cells, other than for medical or veterinary use; chemical substances for use in genetic probe assay kits, not for medical use; biochemicals for in vivo diagnostic scanning agents for scientific use; contrast agents for use in molecular imaging, namely, chemical agents for medical imagery; diagnostic kits comprising specimen receptors and reagents for testing for selected bacteria; enzymes for research purposes; enzyme stabilizers; enzymes other than for medical use, namely, for use in the continuous homogenous isothermal amplifications of specific rna or dna templates; enzymes for use in isothermal amplifications for industrial use; growth stimulants other than for medical or veterinary use, namely, for scientific, laboratory, and research purposes; yeast for scientific purposes; microbial inoculants, other than for medical use, namely, for scientific, laboratory and research purposes; preservatives for pharmaceutical preparations; preservatives for maintaining the viability of micro-organisms in cultures; monoclonal antibodies for in vitro scientific purposes; bacterial preparations for scientific use; nutritive agents for processing living cells, other than for medical use; temperature stabilisers for enzymes; chemical preparations for cryopreservation
10 Medical devices, apparatus and instruments for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; medical devices in the nature of apparatus and instruments for the regeneration of stem cells for medical purposes; medical diagnostic and testing apparatus in the field of genetic testing; tools for medical diagnostics, namely, tools used for analyzing blood cells; diagnostic instruments for medical use for diagnosing diabetes, immune system disorders and genetic disorders; medical diagnostic, examination, and monitoring equipment, namely, apparatus for gene silencing processes; apparatus for tumor diagnosis; apparatus for DNA and RNA testing for medical purposes; genetic testing apparatus for medical purposes; apparatus for the regeneration of stem cells for medical purposes; cell culture instruments for medical use, namely, cell culture chambers; cell counting units for medical use; containers specially designed for transporting samples containing living human cells; medical instruments for therapeutic drug monitoring; medical test kits for diabetes monitoring for home use; diagnostic imaging apparatus for medical or veterinary use for diagnosing medical conditions; automatic analysers for medical or veterinary diagnosis for blood analysis; apparatus for the diagnosis of infectious diseases, cardiovascular diseases, cerebrovascular diseases, inflammatory diseases, gastrointestinal diseases or neurological diseases; scanners for medical or veterinary diagnosis, namely x-ray CT scanners; sensor apparatus for medical or veterinary use in diagnosis of genetic abnormalities; photometric instruments for medical use; precision sensors for medical use, namely, sensors to be worn by patients to gather biometric data; blood collection bags for medical purposes; blood testing equipment; temperature regulation devices, namely, electronic temperature monitors for medical use; temperature sensors and controllers for medical use, namely, thermometers for medical use with embedded software for communicating temperature data to track illness symptoms; controlled rate freezing devices for medical purposes; surgical instruments for the treatment of infectious diseases, viral diseases, parasitic diseases, autoimmunity conditions, vascular diseases, lymphedema, inflammatory diseases, gastrointestinal diseases, neurological conditions, Musculoskeletal diseases, orthopaedic conditions, dermatological conditions, ophthalmic conditions, respiratory diseases, pain, sensory disorders, genitourinary conditions, hormonal conditions, metabolic conditions, monogenic diseases or age-related disorders; cell culture instruments for medical use, namely, flow cytometers, pH meters and incubators; medical devices for use in connection with cell recovery; bags for endoscopic retrieval of tissue; medical devices for the treatment of infectious diseases, viral diseases, parasitic diseases, autoimmunity conditions, vascular diseases, lymphedema, inflammatory diseases, gastrointestinal diseases, neurological conditions, Musculo-skeletal diseases, orthopaedic conditions, dermatological conditions, ophthalmic conditions, respiratory diseases, pain, sensory disorders, genitourinary conditions, hormonal conditions, metabolic conditions, monogenic diseases or age-related disorders; parts and fittings for all the aforesaid goods
42 Research and development in the field of scientific and technology; biological, scientific, clinical and medical research and development; drug discovery; pharmaceutical drug development; providing medical and scientific research information in the field of clinical trials; research relating to genetics; research and development in the field of therapeutics; design of instruments; research and development services relating to bioinformatics; development of computer software, computing methods and algorithms; computer programming in the medical and biological fields; database design; development and maintenance of database software; research and development in the fields of biotechnology, pharmaceuticals, diagnostic preparations, vaccines, medicines, molecular sciences and pharmaceutical therapeutics; scientific research in the field of genetics and genetic engineering; genetic engineering services; genetic modification services; genetic mapping for scientific purposes; research in the field of gene therapy; laboratory research in the field of gene expression; platform as a service, featuring computer software platforms for regulating and modifying genes; chemical engineering; research and development in the field of microorganisms and cells; stem cell research services; culturing of cells for others for scientific research purposes; cell separation research services; cell programming services; biotechnology testing; services for assessing the efficiency of pharmaceuticals; analysis in the field of molecular biology; biological development services; biological cloning services; scientific laboratory services; laboratory testing and analysis services; biological research laboratory services; services of a chemical laboratory; laboratory analysis and research in the fields of bacteriology, gene expression or molecular biology; consultancy relating to research and development in the field of therapeutics; biochemical engineering services; blood analysis services for scientific research purposes; design and development of medical technology; design and development of diagnostic apparatus and equipment; electronic data storage of medical records; computer aided diagnostic testing services for others for scientific research purposes; platform as a service [PaaS] featuring computer software platforms for genetic engineering purposes; software as a service [SaaS] featuring computer software platforms for treatment of symptoms of medical disorders and diseases; development of computer software platforms; programming of software for others for information platforms on the Internet; software engineering; testing of computing methods, algorithms and software; design and development of computer software for use with medical technology; design and development of software for medical diagnostic or veterinary diagnostic purposes; design and development of computer systems for data input, output, processing, display and storage; providing a web hosting platform on the Internet, namely, hosting websites of others in the fields of medical research and healthcare; design services relating to process systems for the biotechnology industry; provision of technical surveys; technical data analysis; database design and development; hosting of databases for others; rental of database management software; scientific research conducted using databases; installation and maintenance of database software; research in the field of artificial intelligence technology; software as a service featuring computer software platforms for artificial intelligence; analysis of human tissues for medical research; research and development services relating to advanced therapies and pharmaceuticals for the treatment of infectious diseases, viral diseases, parasitic diseases, autoimmunity conditions, vascular diseases, lymphedema, inflammatory diseases, gastrointestinal diseases, neurological conditions, Musculo-skeletal diseases, orthopaedic conditions, dermatological conditions, ophthalmic conditions, respiratory diseases, pain, sensory disorders, genitourinary conditions, hormonal conditions, metabolic conditions, monogenic diseases or age-related disorders; consultancy, information and advisory services relating to all of the aforesaid services
therapeutics

Trademark Events
Jul 20, 2023
Sn Assigned For Sect 66a Appl From Ib
Sep 15, 2023
Change Of Name/Address Rec'd From Ib
Jul 21, 2023
New Application Office Supplied Data Entered
Jul 25, 2023
Application Filing Receipt Mailed
Oct 17, 2023
Assigned To Examiner
Nov 13, 2023
Refusal Processed By Ib
Apr 24, 2024
Teas Change Of Owner Address Received
Apr 24, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 18, 2023
Non-Final Action Written
Oct 19, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Oct 26, 2023
Refusal Processed By Mpu
Oct 26, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Apr 24, 2024
Teas Change Of Domestic Representatives Address
Apr 24, 2024
Teas Change Of Correspondence Received
Apr 25, 2024
Teas/Email Correspondence Entered
Apr 25, 2024
Correspondence Received In Law Office
Apr 24, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 24, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 25, 2024
Teas Response To Office Action Received
May 19, 2024
New Representative At Ib Received
May 23, 2024
Final Refusal E-Mailed
May 23, 2024
Final Refusal Written
May 23, 2024
Notification Of Final Refusal Emailed

Trademark Alertz updated from USPTO on 2030-01-24